REGENERATIVE MEDICINE

FROM BENCH TO BEDSIDE






Epidermolysis Bullosa (EB) is a group of genetic adhesion disorders characterized by fragility of the skin. EB are devastating, highly disfiguring, blistering pathologies that severely impairs the quality of life of patients and affect approximately 500,000 people worldwide (www.debra.org).












Skin affected by Epidermolysis Bullosa



Patients with (non lethal) EB develop squamous cell carcinoma with high frequency and have a short life-span expectation. Epidermal stem cell-mediated gene therapy would be the only possible therapy, not only for genodermatoses, but also for other types of genetic skin diseases.


In 2006, our scientists published a proof of principle of the feasibility of ex-vivo gene therapy for laminin 332-dependent Junctional Epidermolysis Bullosa (JEB) by means of transplantation of autologous epidermal sheets prepared from genetically corrected epidemal stem cells. This clinical trial showed that ex vivo gene therapy of JEB is feasible and leads to full functional correction of the disease.















A cultured sheet of genetically corrected epidermis



Holostem Terapie Avanzate is currently running two Phase I/II clinical trials for combined ex-vivo cell and gene therapy for laminin 332-Junctional and Recessive Dystrophic EB, implementing a Phase I/II clinical trial for Col17-JEB and developing new gene-editing technologies for the treatment of dominant forms of EB, in collaboration with the Centre for Regenerative  Medicine "Stefano Ferrari".


GENE THERAPY

FOR EPIDERMOLYSIS BULLOSA

(placeholder)
(placeholder)
(placeholder)

STEM CELLS

TECHNOLOGY

ABOUT US

CELL THERAPY

(placeholder)


MISSION


Provide patients suffering from

severe or rare, untreatable diseases

with stem cell-based advanced therapies

through ethical and scientific excellence

(placeholder)

PUBLICATIONS

STEM CELLS & REGENERATIVE MEDICINE

Tissue integrity and regeneration depend on a population of self-renewing somatic stem cells, above all in constantly renewing tissues. Regenerative Medicine refers to innovative therapies aimed at the permanent restoration of diseased tissues and organs.

(placeholder)

CELL THERAPY

Autologous cultures of limbal stem cells are routinely used for corneal regeneration and restoration of visual acuity in patients with severe corneal chemical and thermal burns associated to total unilateral or severe bilateral limbal stem cell deficiency.

(placeholder)

PUBLICATIONS

Our scientist are author of over 150 peer-reviewed publications in major international journals.


(placeholder)

FOLLOW US ON

¬© 2017  Holostem Terapie Avanzate S.r.l.


VAT: 03213240363 -

Payed Up Capital: Euro 700.000,00

Companies Register Office - Modena: 03213240363

Registered with the Administrative Economic Register: MO-368370

Company subject to the management and coordination of Valline s.r.l.


Holostem Terapie Avanzate Srl

joins Clust-ER Association

"Life Sciences and Wellbeing"


June 2, 2017

NEWS